Recall Register

Food, drugs, devices › Terumo Cardiovascular Systems Corporation

Device recall: CDI 500 Blood Parameter Monitoring System. Provides continuous, on-line monitoring of the extracorporeal partial pressur

FDA enforcement event 71937 · Class II · initiated 7 Aug 2015 · status Terminated · terminated 31 May 2016

DeviceVoluntary: Firm initiated1 product recordAnn Arbor, MI

Terumo Cardiovascular Systems Corporation (Ann Arbor, MI) initiated this device recall on 7 Aug 2015; FDA lists 1 product record under event 71937, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,153 device enforcement events initiated in 2015 carry the same class.

Status: Terminated, terminated 31 May 2016. Initiation: voluntary: firm initiated. Terumo Cardiovascular Systems Corporation has 73 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Terumo Cardiovascular Systems Corporation, Ann Arbor, MI.

Reason for recall

"Inaccuracies in SvO2, temperature, pH, pCO2, pO2, Hematocrit, and Potassium readings following a software upgrade to version 1.69."

Distribution

"Worldwide Distribution-US (nationwide) including DC and PR and the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2742-2015CDI 500 Blood Parameter Monitoring System. Provides continuous, on-line monitoring of the extracorporeal partial pressure of oxygen and and carbon dioxide, pH, potassium, oxygen saturation, hematocrit, hemoglobin and temperature.4638Class IITerminated16 Sep 2015

Context

91%of 2015 device events are Class II1,153 events that year
1product record in this eventfirm median: 2
73events on this register for the firm

Other enforcement events for Terumo Cardiovascular Systems Corporation

InitiatedProduct (first record)TypeClassRecords
28 May 2025CDI OneView System BPM Probe: Cat. No. CDI753 - CDI OneView BPM Probe, Cat. No. CDI753TK - CDI OneView BPM Probe Trial KDeviceClass II1
3 Mar 2025Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe, Catalog Number REF CD1754DeviceClass II1
20 Feb 2024Cardiovascular Procedure Kits that include High Crack Check Valve PN 205307A Part Number: 6375 16010 62974 65246 66312 6DeviceClass II1
1 Mar 2023CAPIOX RX15 Hollow Fiber Oxygenator, Catalog Number 3CX*RX15RE30DeviceClass II3
8 Jun 2021Terumo Advanced Perfusion System 1 Electronic Patient Gas System Catalog #: 801188DeviceClass II1
16 Apr 2021The Terumo HX2 Temperature Management System provides temperature control of two independent water circuits that directlDeviceClass II3
2 Mar 2021Consist of a distal connection mechanism (either standard Terumo Ball Quick Connect or Terumo Shaft Quick Connect), an aDeviceClass II1
11 Nov 2020(1) Capiox FX25 (West) Advance Oxygenator- with left port, 4-liter Reservoir, XC modified to Advance, Sterile Catalog NuDeviceClass II1
25 Aug 2020Terumo Advanced Perfusion System 1 Ultrasonic Air Sensor 3/8x3/32, Catalog Number 5773 - Product Usage: intended for useDeviceClass II3
10 Jan 2020Terumo Advanced Perfusion System 1 Roller Pump, 4 Inch, Catalog Number 816570 - Product Usage: is indicated for use for DeviceClass II4

All 73 events for Terumo Cardiovascular Systems Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Inaccuracies in SvO2, temperature, pH, pCO2, pO2, Hematocrit, and Potassium readings following a software upgrade to version 1.69."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution-US (nationwide) including DC and PR and the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 31 May 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.